Glucocorticoid discontinuation in patients with rheumatoid arthritis who initiated biologic or targeted synthetic agents: a real-world population-based analysis.
BACKGROUND This study aimed to evaluate glucocorticoids (GCs) discontinuation after the initiation of biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in rheumatoid arthritis (RA) patients, using data from a real-world population-based registry. METHODS We analyzed data from RA patient...